Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kunstfeld, R.
26  Ergebnisse:
Personensuche X
?
1

Efficacy and safety of tirbanibulin 1% ointment in actinic ..:

Pellacani, G. ; Schlesinger, T. ; Bhatia, N....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  S1 - p. 3-15 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Quality‐of‐life analysis with intermittent vismodegib regim..:

Schadendorf, D. ; Hauschild, A. ; Fosko, S....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  9 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
3

Long‐term clinical outcomes of imiquimod 5% cream vs. diclo..:

Gollnick, H. ; Dirschka, T. ; Ostendorf, R...
Journal of the European Academy of Dermatology and Venereology.  34 (2019)  1 - p. 82-89 , 2019
Link: https://doi.org/10.1111/..
 
?
4

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N. ; Hauschild, A. ; Kunstfeld, R....
European Journal of Cancer.  86 (2017)  - p. 334-348 , 2017
Link: https://doi.org/10.1016/..
 
?
5

3343 Exploratory analysis of vismodegib (VISMO) treatment d..:

Hauschild, A. ; Hansson, J. ; Grob, J.J....
European Journal of Cancer.  51 (2015)  - p. S681-S682 , 2015
Link: https://doi.org/10.1016/..
 
?
6

Vismodegib (V), un inhibiteur de la voie Hedgehog (HPI), da..:

Grob, J.-J. ; Kunstfeld, R. ; Jouary, T....
Annales de Dermatologie et de Vénéréologie.  140 (2013)  12 - p. S394 , 2013
Link: https://doi.org/10.1016/..
 
?
7

PD.170 Maxillofacial reconstruction after tumour surgery us..:

Vinzenz, K. ; Kunstfeld, R. ; Schaudy, C...
Oral Oncology Supplement.  1 (2005)  1 - p. 118 , 2005
Link: https://doi.org/10.1016/..
 
?
8

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu over..:

Brodowicz, T ; Kandioler, D ; Tomek, S...
British Journal of Cancer.  85 (2001)  11 - p. 1764-1770 , 2001
Link: https://doi.org/10.1054/..
 
?
9

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022.  , 2017
Link: https://hal.science/hal-..
 
?
10

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022.  , 2017
Link: https://hal.science/hal-..
 
?
11

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022.  , 2017
Link: https://hal.science/hal-..
 
?
12

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022.  , 2017
Link: https://hal.science/hal-..
 
?
13

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022.  , 2017
Link: https://hal.archives-ouv..
 
?
14

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/pmid/29073584.  , 2017
Link: http://hdl.handle.net/11..
 
?
15

Die Palliativmedizinische Behandlung von Patienten mit eine..:

Fochtmann, A ; Haymerle, G ; Kunstfeld, R..
http://dx.doi.org/10.3205/14dgpraec176.  , 2014
Link: https://doi.org/10.3205/..
 
1-15